US2017296668A1PendingUtilityA1

Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compound

Assignee: VIZURI HEALTH SCIENCES LLCPriority: Oct 22, 2009Filed: Jun 29, 2017Published: Oct 19, 2017
Est. expiryOct 22, 2029(~3.3 yrs left)· nominal 20-yr term from priority
A61P 33/00A61P 35/00A61P 29/00A61P 31/10A61P 31/00A61K 9/0014A61P 17/06A61P 17/14A61Q 17/04A61K 2800/592A61Q 19/00A61K 9/0095A61K 2800/412A61K 31/7048A61K 9/7023A61K 2800/652A61P 19/02A61K 31/353A61K 47/20A61P 17/10A23L 2/52A61K 47/10A61K 31/00A23L 33/10A61K 8/498A61P 17/00A61P 23/00A61K 47/26A23V 2002/00A61K 31/352A61K 9/70A61K 8/49
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The subject invention relates to novel soluble forms of planar ring structured organic compounds including flavonoids, and their production. The invention also includes the use of these novel formulations of planar ring structured organic compounds in the preparation of formulations and products. The invention also relates to a wide variety of applications of the formulations of the invention. The subject invention includes novel soluble forms and various formulations of flavonoids. Further, the invention includes novel methods of manufacturing the flavonoid formulations. The invention also relates to a wide variety of applications of the flavonoid formulations.

Claims

exact text as granted — not AI-modified
1 . A composition comprising:
 a concentrate formed by mixing a polyphenol with a non-ionic surfactant, in the absence of a carrier, to form a mixture, and heating said mixture to a temperature of greater than 150° C. to form said concentrate, wherein upon cooling to room temperature the concentrate is not supersaturated, and the concentration of said polyphenol is greater than the saturation concentration of said polyphenol in said non-ionic surfactant.   
     
     
         2 . The composition as in  claim 1 , wherein said non-ionic surfactant is a polysorbate. 
     
     
         3 . The composition as in  claim 1  further comprising hyaluronic acid. 
     
     
         4 . The composition as in  claim 1 , wherein said polyphenol and said non-ionic surfactant are heated to a temperature of greater than 170° C. 
     
     
         5 . The composition as in  claim 1  further comprising a carrier. 
     
     
         6 . The composition as in  claim 5 , wherein said carrier is a water based carrier. 
     
     
         7 . The composition as in  claim 5 , wherein said carrier comprises dimethyl sulfoxide and water. 
     
     
         8 . The composition as in  claim 5 , wherein said carrier comprises dimethyl sulfoxide, hydroxypropyl cellulose and water. 
     
     
         9 . The composition as in  claim 5 , wherein said carrier comprises ethanol, propylene glycol and water. 
     
     
         10 . The composition as in  claim 5 , wherein said carrier comprises ethanol, propylene glycol, water and a gelling agent selected from the group consisting of hydroxyethyl cellulose, sodium hyaluronate and carbopol. 
     
     
         11 . The composition as in  claim 5 , wherein said carrier comprises an oil phase, a surfactant, and water. 
     
     
         12 . The composition as in  claim 11 , wherein said oil phase comprises ethoxydiglycol, myristyl lactate, cyclomethicone or oleyl alcohol. 
     
     
         13 . The composition as in  claim 5 , wherein said carrier is an oil based carrier. 
     
     
         14 . The composition as in  claim 5 , wherein said carrier comprises an alcohol, ethoxydiglycol, propylene glycol, hexylene glycol, butylene glycol, dipropylene glycol, glycerin, water, saline, DMSO, isopropyl myristate, mineral oil, a surfactant, or dimethyl isosorbide. 
     
     
         15 . The composition as in  claim 1 , wherein said non-ionic surfactant is polysorbate 13, polyoxy 20 cetostearyl, or polyoxyl 40 hydrogenated castor oil. 
     
     
         16 . The composition as in  claim 1 , wherein said composition is in the form of a pharmaceutical. 
     
     
         17 . The composition as in  claim 1 , wherein said composition is in the form of a nutraceutical, cosmeceutical, food or medical food. 
     
     
         18 . The composition as in  claim 1 , wherein said composition is in the form of a beverage. 
     
     
         19 . The composition as in  claim 1 , wherein said composition is in the form of a solution or emulsion. 
     
     
         20 . The composition as in  claim 1 , wherein said composition is in the form of a gelatin capsule or enteric coated capsule. 
     
     
         21 . The composition as in  claim 1 , wherein said composition is in the form of a liquid, serum, cream, lotion, gel, spray, foam, ointment or cleanser. 
     
     
         22 . The composition as in  claim 1 , further comprising one or more additive selected from the group consisting of hyaluronic acid, a preservative, a buffer, a humectant, an anti-inflammatory agent, an emollient, a moisturizer, a thickening agent, and an analgesic.

Join the waitlist — get patent alerts

Track US2017296668A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.